Crewe Advisors’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.1K Buy
+143
New +$11.5K ﹤0.01% 715
2026
Q1
Sell
-62
Closed -$4.89K 1103
2025
Q4
$4.89K Buy
62
+29
+88% +$2.29K ﹤0.01% 731
2025
Q3
$2.72K Buy
+33
New +$2.6K ﹤0.01% 804
2024
Q3
Sell
-562
Closed -$39.4K 881
2024
Q2
$39.4K Buy
562
+482
+603% +$34.4K ﹤0.01% 410
2024
Q1
$5.93K Buy
+80
New +$5.58K ﹤0.01% 699
2023
Q4
Sell
-7
Closed -$441 590
2023
Q3
$441 Hold
7
﹤0.01% 395
2023
Q2
$396 Sell
7
-129
-95% -$7.16K ﹤0.01% 652
2023
Q1
$7.88K Hold
136
﹤0.01% 583
2022
Q4
$9.84K Sell
136
-239
-64% -$17.1K ﹤0.01% 553
2022
Q3
$23K Buy
375
+43
+13% +$2.75K ﹤0.01% 435
2022
Q2
$21K Buy
+332
New +$22K ﹤0.01% 409
2021
Q3
Sell
-16
Closed -$1K 439
2021
Q2
$1K Sell
16
-72
-82% -$4.56K ﹤0.01% 443
2021
Q1
$5K Hold
88
﹤0.01% 372
2020
Q4
$4K Sell
88
-59
-40% -$2.56K ﹤0.01% 369
2020
Q3
$5K Buy
+147
New +$5.58K ﹤0.01% 356
2019
Q3
Sell
-12
Closed -$1K 282
2019
Q2
$1K Hold
12
﹤0.01% 289
2019
Q1
$1K Buy
+12
New +$531 ﹤0.01% 235

Other funds holding MET

Crewe Advisors's MET Position: Q2 2026 in Review

Crewe Advisors opened a new position in MetLife (MET) in Q2 2026: 143 shares worth $12.1K. The stake represents ﹤0.01% of the portfolio and ranks #715 among its holdings. This is a return to the name: Crewe Advisors previously reported a position in MET as recently as Q4 2025.

Crewe Advisors first reported a position in MET in Q1 2019 and has held it in 17 quarters since. The position peaked at $39.4K in Q2 2024. 1,442 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Crewe Advisors held 143 shares of MetLife worth $12.1K as of Q2 2026.
  • MetLife was a new Crewe Advisors position in Q2 2026.
  • MetLife made up ﹤0.01% of Crewe Advisors's portfolio in Q2 2026, its #715 holding.
  • Crewe Advisors first reported a position in MetLife in Q1 2019 and has held it in 17 quarters since.
  • Crewe Advisors's MetLife position peaked at $39.4K in Q2 2024.
  • 1,442 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Crewe Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.